Mifepristone is an evidence-based treatment prescribed for management of early pregnancy loss as well as induced abortion. Although mifepristone has long been proven to be safe and effective when prescribed through telemedicine and can be safely taken in the comfort of a patient’s home, outdated FDA restrictions require mifepristone to be dispensed in a hospital, clinic, or medical office.| www.acog.org
The FDA announced that it will not enforce the in-person dispending requirement for mifepristone for the duration of the COVID-19 public health emergency.| www.acog.org
Clinical Considerations and Recommendations| www.acog.org
Teratogenicity and Ongoing Pregnancy| www.acog.org
(Reaffirmed October 2024)| www.acog.org
The challenge to mifepristone approval in the lawsuit Alliance for Hippocratic Medicine v. FDA has created and perpetuated legal complexity and caused widespread confusion among patients and clinicians, including ACOG members.| www.acog.org